Breakfast Technical Briefing on Medical Equipment Stocks -- Hologic, Wright Medical, Edwards Lifesciences, and Stryker

Friday, July 28, 2017 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, July 28, 2017 /PRNewswire/ --

If you want a Stock Review on HOLX, WMGI, EW, or SYK then come over to http://dailystocktracker.com/register/

and sign up for your free customized report today. DailyStockTracker.com has issued research reports on Hologic Inc. (NASDAQ: HOLX), Wright Medical Group N.V. (NASDAQ: WMGI), Edwards Lifesciences Corp. (NYSE: EW), and Stryker Corp. (NYSE: SYK). Companies
in the Medical Appliances and Equipment space are engaged in the manufacture of medical instruments such as dental and surgical appliances. Most of the time, they are structured as corporations. Daily Stock Tracker published free research reports on these stocks today at:

http://dailystocktracker.com/register/

Hologic 

Marlborough, Massachusetts headquartered Hologic Inc.'s shares dropped 1.55%, closing Thursday's trading session at $44.44. The stock recorded a trading volume of 1.86 million shares. Shares of the Company have advanced 10.77% since the start of this year. The stock is trading 6.98% above its 200-day moving average. Additionally, shares of Hologic, which develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the US, Europe, the Asia-Pacific, and internationally, have a Relative Strength Index (RSI) of 45.67.  

On July 05th, 2017, Hologic announced that it plans to release its financial results for Q3 FY17 on August 02nd, 2017, after the market closes. In conjunction with the release, management will host a conference call at 4:30 p.m. ET. A live webcast of the call may be accessed on the Company's website. See our free and comprehensive research report on HOLX at:

http://dailystocktracker.com/registration/?symbol=HOLX

Wright Medical 

On Thursday, shares in Amsterdam, the Netherlands headquartered Wright Medical Group N.V. recorded a trading volume of 1.23 million shares, which was above their three months average volume of 1.01 million shares. The stock rose 1.58%, ending the day at $28.37. The Company's shares have advanced 7.34% in the past month and 23.46% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.76% and 7.66%, respectively. Furthermore, shares of Wright Medical, which designs, manufactures, markets, and sells extremities and biologics products in the US, Europe, Middle-East, Africa, and internationally, have an RSI of 64.45.  

On June 30th, 2017, research firm Cantor Fitzgerald initiated an 'Overweight' rating on the Company's stock, with a target price of $33 per share.

On July 05th, 2017, Wright Medical announced that it will host a conference call on August 02nd, 2017, at 3:30 p.m. CT to discuss the Company's operating results for its Q2 ended June 25th, 2017. Operating results will be released at 3:00 p.m. CT on that same day. A simultaneous webcast of the call will be available on the Company's corporate website. WMGI free research report is just a click away at:

http://dailystocktracker.com/registration/?symbol=WMGI

Edwards Lifesciences 

Irvine, California headquartered Edwards Lifesciences Corp.'s stock finished the day 0.65% higher at $116.36. A total volume of 3.53 million shares was traded, which was above their three months average volume of 1.20 million shares. Shares of the Company have advanced 6.10% in the previous three months and 24.18% on an YTD basis. The stock is trading above its 200-day moving average by 14.96%. Additionally, shares of Edwards Lifesciences, which provides products and technologies to treat structural heart disease and critically ill patients worldwide, have an RSI of 47.46.  

On July 26th, 2017, Edwards Lifesciences reported financial results for the quarter ended June 30th, 2017. Sales for Q2 2017 were $841.8 million; adjusted earnings per share grew 42.1% to $1.08; gross profit margin was 74.9%; selling, general, and administrative expenses increased to $243.8 million; and R&D investments increased to $134.4 million. Cash, cash equivalents, and short-term investments totaled $1.13 billion at June 30th, 2017. Additionally, total debt was $1.02 billion.

On July 27th, 2017, research firm Stifel reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $118 a share to $130 a share. Sign up for your complimentary report on EW at:

http://dailystocktracker.com/registration/?symbol=EW

Stryker 

Shares in Kalamazoo, Michigan headquartered Stryker Corp. ended yesterday's session 1.17% lower at $144.05. The stock recorded a trading volume of 1.47 million shares, which was above its three months average volume of 1.08 million shares. The Company's shares have advanced 3.20% in the last one month, 6.41% over the previous three months, and 20.23% since the start of this year. The stock is trading 1.70% and 12.61% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Stryker, which together with its subsidiaries, operates as a medical technology company, have an RSI of 52.07.

On June 30th, 2017, research firm Cantor Fitzgerald initiated a 'Neutral' rating on the Company's stock, with a target price of $153 per share. Register for free on DailyStockTracker.com and download the latest research report on SYK at:

http://dailystocktracker.com/registration/?symbol=SYK

--

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook